The Blood Product Market is anticipated to reach USD 0.47 billion by 2033, growing from USD 0.33 billion in 2023 at a compound annual growth rate (CAGR) of 4.32% over the forecast period. Blood products are medical substances derived from human blood used for therapeutic purposes. These products encompass whole blood, blood components such as red blood cells, white blood cells, platelets, and plasma, as well as plasma-derived products like clotting factors and immunoglobulins. They play a critical role in treating various medical conditions including anemia, clotting disorders, and immune deficiencies, and are essential in surgical and trauma care. These products are meticulously collected, processed, and tested to ensure their safety and compatibility for transfusions and other medical applications.
The latest research report by Evolve Business Intelligence explores the various factors influencing the global market. It includes an analysis of the current market size, forecasts for key segments and regions, and the driving forces behind market growth. The report examines the potential impacts of key trends on business strategies and provides a SWOT analysis of critical sectors for each major competitor and customer group. This valuable data highlights the conglomerates likely to impact the industry, crucial for any company planning to invest strategically over the next five years. These insights complement our initial quantitative study, aiding in new investments and strategic planning to mitigate threats in existing sectors.
Segments covered
By Type (Coagulation Factor, Immune Globulin, Albumin)
By Application (Surgery, Therapy, Immunity)
Key players
GRIFOLS
RELIANCE LIFE SCIENCE
BHARAT SERUMS AND VACCINES
INTAS PHARMACEUTICALS
HEMARUS
TAKEDA PHARMACEUTICAL COMPANY
OCTAPHARMA
PLASMAGEN BIOSCIENCES
NEXUS LIFECARE
KEDRION
BPL (BIO PRODUCTS LABORATORY LTD.)
HUALAN BIOLOGICAL ENGINEERING INC
BAXTER
MITSUBISHI TANABE PHARMA
CSL
SHANGHAI RAAS
- Chapter 1. Executive Summary
- Chapter 2. Scope Of The Study
- 2.1. Market Definition
- 2.2. Scope Of The Study
- 2.2.1. Objectives of Report
- 2.2.2. Limitations
- 2.3. Market Structure
- Chapter 3. Evolve BI Methodology
- Chapter 4. Market Insights and Trends
- 4.1. Supply/ Value Chain Analysis
- 4.1.1. Raw End Users Providers
- 4.1.2. Manufacturing Process
- 4.1.3. Distributors/Retailers
- 4.1.4. End-Use Industry
- 4.2. Porter’s Five Forces Analysis
- 4.2.1. Threat Of New Entrants
- 4.2.2. Bargaining Power Of Buyers
- 4.2.3. Bargaining Power Of Suppliers
- 4.2.4. Threat Of Substitutes
- 4.2.5. Industry Rivalry
- 4.3. Impact Of COVID-19 on the Blood Product Market
- 4.3.1. Impact on Market Size
- 4.3.2. End-Use Industry Trend, Preferences, and Budget Impact
- 4.3.3. Regulatory Framework/Government Policies
- 4.3.4. Key Players' Strategy to Tackle Negative Impact
- 4.3.5. Opportunity Window
- 4.4. Technology Overview
- 12.28. Macro factor
- 4.6. Micro Factor
- 4.7. Demand Supply Gap Analysis of the Blood Product Market
- 4.8. Import Analysis of the Blood Product Market
- 4.9. Export Analysis of the Blood Product Market
- Chapter 5. Market Dynamics
- 5.1. Introduction
- 5.2. DROC Analysis
- 5.2.1. Drivers
- 5.2.2. Restraints
- 5.2.3. Opportunities
- 5.2.4. Challenges
- 5.3. Patent Analysis
- 5.4. Industry Roadmap
- 5.5. Parent/Peer Market Analysis
- Chapter 6. India Blood Product Market, By Type
- 6.1. Introduction
- 6.2. Coagulation Factor
- 6.3. Immune Globulin
- 6.4. Albumin
- Chapter 7. India Blood Product Market, By Application
- 7.1. Introduction
- 7.2. Surgery
- 7.3. Therapy
- 7.4. Immunity
- Chapter 8. Company Landscape
- 8.1. Introduction
- 8.2. Vendor Share Analysis
- 8.3. Key Development Analysis
- 8.4. Competitor Dashboard
- Chapter 9. Company Profiles
- 9.1. GRIFOLS
- 9.1.1. Business Overview
- 9.1.2. Government & Defense Analysis
- 9.1.2.1. Government & Defense – Existing/Funding
- 9.1.3. Product Portfolio
- 9.1.4. Recent Development and Strategies Adopted
- 9.1.5. SWOT Analysis
- 9.2. RELIANCE LIFE SCIENCE
- 9.2.1. Business Overview
- 9.2.2. Government & Defense Analysis
- 9.2.2.1. Government & Defense – Existing/Funding
- 9.2.3. Product Portfolio
- 9.2.4. Recent Development and Strategies Adopted
- 9.2.5. SWOT Analysis
- 9.3. BHARAT SERUMS AND VACCINES
- 9.3.1. Business Overview
- 9.3.2. Government & Defense Analysis
- 9.3.2.1. Government & Defense – Existing/Funding
- 9.3.3. Product Portfolio
- 9.3.4. Recent Development and Strategies Adopted
- 9.3.5. SWOT Analysis
- 9.4. INTAS PHARMACEUTICALS
- 9.4.1. Business Overview
- 9.4.2. Government & Defense Analysis
- 9.4.2.1. Government & Defense – Existing/Funding
- 9.4.3. Product Portfolio
- 9.4.4. Recent Development and Strategies Adopted
- 9.12.28. SWOT Analysis
- 9.5. HEMARUS
- 9.5.1. Business Overview
- 9.5.2. Government & Defense Analysis
- 9.5.2.1. Government & Defense – Existing/Funding
- 9.5.3. Product Portfolio
- 9.5.4. Recent Development and Strategies Adopted
- 9.5.5. SWOT Analysis
- 9.6. TAKEDA PHARMACEUTICAL COMPANY
- 9.6.1. Business Overview
- 9.6.2. Government & Defense Analysis
- 9.6.2.1. Government & Defense – Existing/Funding
- 9.6.3. Product Portfolio
- 9.6.4. Recent Development and Strategies Adopted
- 9.6.5. SWOT Analysis
- 9.7. OCTAPHARMA
- 9.7.1. Business Overview
- 9.7.2. Government & Defense Analysis
- 9.7.2.1. Government & Defense – Existing/Funding
- 9.7.3. Product Portfolio
- 9.7.4. Recent Development and Strategies Adopted
- 9.7.5. SWOT Analysis
- 9.8 PLASMAGEN BIOSCIENCES
- 9.8.1. Business Overview
- 9.8.2. Government & Defense Analysis
- 9.8.2.1. Government & Defense – Existing/Funding
- 9.8.3. Product Portfolio
- 9.8.4. Recent Development and Strategies Adopted
- 9.8.5. SWOT Analysis
- 9.9 NEXUS LIFECARE
- 9.9.1. Business Overview
- 9.9.2. Government & Defense Analysis
- 9.9.2.1. Government & Defense – Existing/Funding
- 9.9.3. Product Portfolio
- 9.9.4. Recent Development and Strategies Adopted
- 9.9.5. SWOT Analysis
- 9.10. KEDRION
- 9.10.1. Business Overview
- 9.10.2. Government & Defense Analysis
- 9.10.2.1. Government & Defense – Existing/Funding
- 9.10.3. Product Portfolio
- 9.10.4. Recent Development and Strategies Adopted
- 9.10.5. SWOT Analysis
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook